1-1 of 1
Herman Van Besien, BA
Close
Sort by
Journal Articles

Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes

Destini Gibbs, Herman Van Besien, BA, Stephenson Regan, Ankur Singh, PhD, Matthew Teater, Ethel Cesarman, MD PhD, Ari Melnick, MD, Lisa Giulino Roth, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 304.
https://doi.org/10.1182/blood-2019-126790
Published: 2019